SCHEMBL7090602

SCHEMBL7090602

C=C(C)[S+]([O-])SC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17827076 0.65
SCHEMBL777007 0.65
SCHEMBL469827 0.62
SCHEMBL3240862 0.62
SCHEMBL4825808 0.62
SCHEMBL9914182 0.62
SCHEMBL4817385 0.58
SCHEMBL862565 0.55
SCHEMBL677890 0.55
SCHEMBL7886845 0.53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030077264-A1 Antimicrobial blood treatment using allicin and related compounds GAMBRO, INC. 2003-04-24 US claimed
WO-2003075901-A2 USE OF S-SUBSTITUTED L-CRYSTEINE FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS GHISALBERTI CARLO (BR) 2003-09-18 WO disclosed
US-20030077264-A1 Antimicrobial blood treatment using allicin and related compounds GAMBRO, INC. 2003-04-24 US disclosed